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stenting
Rodney P. Bensley, MD, Shunsuke Yoshida, MD, Ruby C. Lo, MD, Margriet Fokkema, MD,
Allen D. Hamdan, MD, Mark C. Wyers, MD, Elliot L. Chaikof, MD, PhD, and
Marc L. Schermerhorn, MD, Boston, Mass
Objective: Administrative data have been used to compare carotid endarterectomy (CEA) and carotid artery stenting
(CAS). However, there are limitations in deﬁning symptom status, Centers for Medicare and Medicaid Services high-risk
status, as well as complications. Therefore, we did a direct comparison between administrative data and physician chart
review as well as between data collected for the National Surgical Quality Improvement Program (NSQIP) and physician
chart review for CEA and CAS.
Methods: We performed an outcomes analysis on all CEA and CAS procedures from 2005 to 2011. We obtained Inter-
national Classiﬁcation of Diseases, Ninth Revision diagnosis codes from hospital discharge records regarding symptom
status, high-risk status, and perioperative stroke. We also obtained data on all CEA patients submitted to NSQIP over the
same time period. One of the study authors (R.B.) then performed a chart review of the same patients to determine
symptom status, high-risk status, and perioperative strokes and the results were compared.
Results: We identiﬁed 1342 patients who underwent CEA or CAS between 2005 and 2011 and 392 patients who
underwent CEA that were submitted to NSQIP. Administrative data identiﬁed fewer symptomatic patients (17.0% vs
34.0%), physiologic high-risk patients (9.3% vs 23.0%), and anatomic high-risk patients (0% vs 15.2%). Although
administrative data identiﬁed a similar proportion of perioperative strokes (1.9% vs 2.0%), this was due to the fact that
these data identiﬁed eight false positive and nine false negative perioperative strokes. NSQIP data identiﬁed more
symptomatic patients compared with chart review (44.1% vs 30.3%), fewer physiologic high-risk patients (13.0% vs
18.6%), fewer anatomic high-risk patients (0% vs 6.6%), and a similar proportion of perioperative strokes (1.5% vs 1.8%,
only one false negative stroke and no false positives).
Conclusions: Administrative data are unreliable for determining symptom status, high-risk status, and perioperative
stroke and should not be used to analyze CEA and CAS. NSQIP data do not adequately identify high-risk patients,
but do accurately identify perioperative strokes and to a lesser degree, symptom status. (J Vasc Surg 2013;58:412-20.)Administrative data have been utilized to compare
carotid endarterectomy (CEA) and carotid artery stenting
(CAS).1-3 Large databases populated with administrative
data are valuable research tools. However, the accuracy
of administrative data in determining pre-existing disease,
symptom status, high-risk status, and perioperative compli-
cations has been questioned.4 Studies utilizing thethe Department of Surgery, Division of Vascular and Endovascular
rgery,Beth IsraelDeaconessMedicalCenter andHarvardMedical School.
work was supported by the NIH T32 Harvard-Longwood Research
raining in Vascular Surgery grant HL007734.
or conﬂict of interest: Dr Schermerhorn is a consultant for Endologix,
edtronic, and Boston Scientiﬁc.
ented at the plenary session of the Thirty-seventh Annual Meeting of
e Peripheral Vascular Surgery Society, National Harbor, Md, June
2012.
rint requests: Marc L. Schermerhorn, MD, Department of Surgery,
ivision of Vascular and Endovascular Surgery, Beth Israel Deaconess
edical Center, Harvard Medical School, 110 Francis St, Ste 5B, Boston,
A 02215 (e-mail: mscherm@bidmc.harvard.edu).
editors and reviewers of this article have no relevant ﬁnancial relationships
disclose per the JVS policy that requires reviewers to decline review of any
anuscript for which they may have a conﬂict of interest.
-5214/$36.00
yright  2013 by the Society for Vascular Surgery.
://dx.doi.org/10.1016/j.jvs.2013.01.010Nationwide Inpatient Sample report that 90%-97% of the
patients undergoing carotid revascularization are asymp-
tomatic,1-3 whereas multicenter studies and retrospective
reviews report that only 56%-72% of patients are asymp-
tomatic.5-8 International Classiﬁcation of Diseases, Ninth
Revision (ICD-9) codes are nonspeciﬁc and imprecise.
They do not specify the extent of disease within a diagnosis
(eg, class III-IV congestive heart failure [CHF]), do not
provide laterality of disease, and lack the temporal timing
of onset. These limitations with ICD-9 codes limit the
ability to distinguish pre-existing disease from new disease
and perioperative complications.
Other large datasets that utilize clinical data, such as
the National Surgical Quality Improvement Program
(NSQIP), may provide a more accurate measurement of
symptom status, high-risk status, and perioperative
complications. NSQIP is not reliant on hospital coders.
Trained clinical nurse reviewers input data prospectively.
However, the current iteration of NSQIP does not have
procedure-speciﬁc comorbidities or complications. For
example, a history of transient ischemic attack (TIA) or
stroke are obtained but may have occurred more than
6 months before surgery or may have been contralateral
to the carotid undergoing treatment. Similarly, there is
JOURNAL OF VASCULAR SURGERY
Volume 58, Number 2 Bensley et al 413no measure of disease severity. The ability to accurately
determine symptom status and high-risk status with
NSQIP has not been studied. The purpose of this study
is to determine the accuracy with which administrative
data and NSQIP data capture symptom status, high-risk
status, and perioperative complications compared with
chart review by a trained physician.
METHODS
Patients. We obtained hospital administrative dis-
charge data on all patients undergoing CEA or CAS from
January 1, 2005 to December 31, 2011 at our institution.
Patients were identiﬁed using ICD-9 procedure codes for
CEA (38.12) or CAS (00.63). We also identiﬁed all
patients undergoing CEA at our institution that were
submitted to NSQIP. We used our institution’s adminis-
trative discharge data and prospectively collected clinical
data submitted to NSQIP, to determine symptom status,
high-risk status, and perioperative stroke and compared
these results with physician chart review. This study was
approved by the Institutional Review Board at Beth Israel
Deaconess Medical Center and Harvard Medical School.
Hospital administrative discharge data. We identi-
ﬁed patients undergoing CEA or CAS. Patients having
coronary artery bypass (CABG) (36.11-36.16) or cardiac
valve repair (35.X) during the same hospitalization were
identiﬁed. All ICD-9 diagnosis codes associated with
each patient’s discharge record were reviewed to de-
termine symptom status and physiologic and anatomic
high-risk status. Physiologic high-risk variables include
age >80 years, CHF class III/IV, left ventricular ejection
fraction (LVEF) <30%, unstable angina, myocardial
infarction (MI) within 30 days, severe lung disease (forced
expiratory volume in 1 second <30% of predicted or home
oxygen), hemodialysis, and CABG or valve repair within
30 days. Anatomic high-risk variables include contralateral
laryngeal nerve palsy, restenosis after prior CEA, radiation
therapy to the neck, a high lesion, prior neck surgery, and
contralateral internal carotid artery occlusion. Patients were
considered symptomatic if they had ICD-9 codes for TIA
(435.X, 781.4, V12.54), amaurosis fugax/retinal vascular
occlusion (362.3X, 368.12), or stroke (433.11, 433.31,
433.91, 434.01, 434.11, 434.91). Patients without any of
these diagnosis codes were considered asymptomatic. As
has been previously reported, ICD-9 diagnosis codes were
used to identify comorbid conditions that would qualify
the patient for Centers for Medicare and Medicaid Services
(CMS) physiologic high-risk status 3 (Table I). Patients
without these conditions were considered non-high
risk. Perioperative strokes were identiﬁed using ICD-9
code 997.02 (iatrogenic cerebrovascular infarction or
hemorrhage).
Prospectively collected NSQIP data. NSQIP is
a national multi-institutional, risk-adjusted, prospectively
collected clinical database created to facilitate quality
control review of outcomes. The registry collects infor-
mation on demographics, comorbidities, intraoperative
information, and 30-day perioperative outcomes. Speciallytrained clinical nurse reviewers, trained by the ACS, input
data at each participating institution using standardized
deﬁnitions. We obtained a list of all patients undergoing
CEA at our institution whose data were submitted to
NSQIP. We calculated the proportion of patients that were
symptomatic, physiologic and anatomic high-risk, and
those with perioperative strokes. Physiologic high-risk
variables utilized in NSQIP include age >80 years, active
CHF, MI within 6 months, angina within 1 month, and
hemodialysis.9 Patients were considered symptomatic if
they had a history of TIA or stroke.
Physician chart review. One of the study authors
(R.B.) performed a thorough chart review of the same
patients identiﬁed using hospital administrative data and
the patients submitted to NSQIP. The senior author clari-
ﬁed all questions encountered during chart review.
Symptom status, physiologic and anatomic high-risk
status, and perioperative strokes were identiﬁed. Symp-
tomatic was deﬁned as ipsilateral carotid territory TIA or
stroke within 6 months of their carotid procedure.
Discrepancies in the identiﬁcation of symptom status, high-
risk status, and perioperative strokes were identiﬁed and
recorded. The majority of patients were not examined by
a neurologist unless there was a suspicion for a perioper-
ative stroke or if they were enrolled in a clinical trial
requiring neurologic evaluation.
Deﬁning high-risk variables. CMS has speciﬁc
criteria deﬁning high-risk for CEA.10 When performing
chart review, all CMS guidelines were adhered to when
identifying both physiologic and anatomic high-risk
patients. However, ICD-9 coding lacks the level of detail
and speciﬁcity outlined by CMS. Furthermore, there are no
ICD-9 codes for anatomic high-risk variables so these were
unable to be assessed with administrative data. NSQIP has
speciﬁc deﬁnitions of comorbidities that differ from CMS11
and lacks anatomic details. Table I lists high-risk variables
(physiologic and anatomic) and how they are identiﬁed
and deﬁned by CMS, administrative data, and NSQIP,
respectively.
Statistical analysis. We calculated the proportion of
patients who were considered symptomatic, physiologic
high-risk, anatomic high-risk, and who experienced a peri-
operative stroke by administrative data and NSQIP data,
respectively, and then compared them with physician chart
review of the same patients. We then calculated the sensi-
tivity, speciﬁcity, positive predictive value (PPV), negative
predictive value (NPV), and kappa coefﬁcient of the ability
of administrative data and NSQIP data to properly identify
symptom status, high-risk status, and perioperative strokes
as compared with chart review (Fig 1 shows the 2  2 table
used to calculate the sensitivity, speciﬁcity, PPV, and
NPV). Sensitivity measures the accuracy of identifying
a variable (ie, symptomatic, high-risk) as being present in
patients in whom it truly is present. Speciﬁcity measures the
accuracy of identifying a variable as being absent in patients
who do not have the variable. PPV measures the propor-
tion of patients identiﬁed as having a variable that truly
have the variable. NPV measures the proportion of patients
Table I. Physiologic and anatomic high-risk variables and how they are deﬁned by the CMS, administrative data, and the
NSQIP database
CMS deﬁnitions Administrative data NSQIP deﬁnitions
Physiologic high risk
Age >80 years Age >80 years Age >80 years
Recent MI within 30 days 412b History of a non-Q wave or a Q wave MI
within 6 months of surgery
Unstable angina 411.1b Angina within 30 days of surgery
CHF class III or IV 428b Newly diagnosed CHF or chronic CHF with
new symptoms within 30 days of surgery
LVEF <30% Unavailable Unavailable
Hemodialysis 585.3-585.9, 586, V42.0, V45.1-V45.12,
V56.0 - V56.32, V56.8b
Acute or chronic renal failure requiring
peritoneal dialysis, hemodialysis,
hemoﬁltration, hemodiaﬁltration, or
ultraﬁltration within 2 weeks of surgery
Severe pulmonary diseasea 490-492.8, 493, 494-494.1, 495-505, 506.4b Severe COPDc
CABG/valve repair within 30 days 36.11-36.16, 35b CABG/valve repair performed at the same
time as CEA
Anatomic high risk
Contralateral ICA occlusion Unavailable Unavailable
Restenosis after CEA Unavailable Unavailable
Prior neck surgery Unavailable Unavailable
Contralateral laryngeal nerve palsy Unavailable Unavailable
History of neck irradiation Unavailable Unavailable
High or low lesion Unavailable Unavailable
CABG, Coronary artery bypass grafting; CEA, carotid endarterectomy; CHF, congestive heart failure; CMS, Centers for Medicare and Medicaid Services;
COPD, chronic obstructive pulmonary disease; ICA, internal carotid artery; ICD-CM, International Classiﬁcation of Diseases, Ninth Revision-clinically
modiﬁed; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NSQIP, National Surgical Quality Improvement Program.
aForced expiratory volume in 1 second <30% of predicted or home oxygen.
bICD-9-CM codes.
cFunctional disability from COPD, hospitalization for treatment of COPD, chronic bronchodilator therapy, or a forced expiratory volume in 1 second <75%
of predicted.
Fig 1. The 2  2 table used to calculate sensitivity, speciﬁcity,
positive predictive value (PPV), and negative predictive value
(NPV). NSQIP, National Surgical Quality Improvement Program.
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that variable. Kappa is a measure of agreement beyond
chance between two databases or methods of identifying
data. Kappa values >0.75 indicate excellent agreement,0.40-0.75 fair to good agreement, and values <0.4 poor
agreement. All statistical tests were performed using
STATA 12 software (StataCorp, College Station, Tex).RESULTS
Administrative data identiﬁed 1342 patients who
underwent carotid revascularization (1055 CEA and 287
CAS) at our institution from 2005 to 2011. We identiﬁed
392 CEA patients submitted to NSQIP, all of whom were
included in the 1055 CEA patients identiﬁed by adminis-
trative data. A chart review was then performed of the
1342 patients identiﬁed with administrative data and the
392 patients submitted to NSQIP to make direct compar-
isons to each method (Fig 2).
Comparison of administrative data and physician chart
review
Comparing administrative data to chart review, admin-
istrative data identiﬁed fewer symptomatic patients (17.0%
vs 34.0%), fewer physiologic high-risk patients (9.3% vs
23.0%), fewer anatomic high-risk patients (0% vs 15.2%),
and a similar proportion of perioperative strokes (1.9% vs
2.0%). When examining individual high-risk variables,
administrative data overestimated recent MI, CHF, hemo-
dialysis, and severe pulmonary disease, whereas underesti-
mating unstable angina, LVEF <30%, and CABG/valve
Fig 2. Flow diagram depicting all patients captured by administrative data, National Surgical Quality Improvement
Program (NSQIP) data, and physician chart review. CAS, Carotid artery stenting; CEA, carotid endarterectomy.
Table II. Comparison of outcomes analysis using
administrative data and physician chart review in 1342
patients who underwent CEA or CAS between 2005
and 2011
Adminis-
trative
data
Physician
chart
review
No. % No. %
Symptomatic 228 17.0 456 34.0
Physiologic high risk 125 9.3 308 23.0
Age >80 years 265 19.7 265 19.7
Recent MI 174 13.0 9 0.7
Unstable angina 1 0.0 16 1.2
CHF class III or IV 125 9.3 10 0.7
LVEF <30% - - 35 2.6
Hemodialysis 108 8.0 13 1.0
Severe pulmonary diseasea 250 18.6 15 1.1
CABG/valve repair within 30 days 32 2.4 48 3.6
Anatomic high risk - - 204 15.2
Contralateral ICA occlusion - - 82 6.1
Restenosis after CEA - - 108 8.0
Prior neck surgery - - 41 3.1
Contralateral laryngeal nerve palsy - - 2 0.1
History of neck irradiation - - 29 2.2
High or low lesion - - 29 2.2
Perioperative stroke 26 1.9 27 2.0
CABG, Coronary artery bypass grafting; CEA, carotid endarterectomy;
CHF, congestive heart failure; ICA, internal carotid artery; LVEF, left
ventricular ejection fraction; MI, myocardial infarction.
aForced expiratory volume in 1 second <30% of predicted or home oxygen.
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anatomic high-risk variables using ICD-9 codes.
Symptom status. Administrative data identiﬁed 228
symptomatic patients, whereas chart review identiﬁed 456.
However, there was poor overlap. Of 228 symptomatic
patients identiﬁedby administrative data, only 167were truly
symptomatic. This means that 289 of the 456 symptomaticpatients identiﬁed by chart reviewweremisclassiﬁed as being
asymptomatic by administrative data. The sensitivity of
administrative data for determining symptom status is
36.6%, speciﬁcity 93.1%, PPV 73.2%, and NPV 74.1%. The
kappa is 0.34, indicating poor agreement between adminis-
trative data and chart review (Table III).
High-risk status. Administrative data identiﬁed 125
physiologic high-risk patients, whereas chart review iden-
tiﬁed 308. Only 60 of the 125 were truly physiologic high-
risk, leaving 248 of the 308 misclassiﬁed by administrative
data as being non-high risk. The sensitivity of adminis-
trative data for determining high-risk status is 19.5%,
speciﬁcity 93.7%, PPV 48.0%, and NPV 79.6%. The kappa
is 0.17, indicating poor agreement between administrative
data and chart review. There was also poor concordance
with the individual high-risk variables with the exception
of age >80 years and CABG/valve repair (Table III). The
kappa for age >80 and CABG/valve repair is 1.00 and
0.78, respectively, indicating excellent agreement. The
kappa for the other high-risk variables ranges from 0.03
to 0.11 indicating poor agreement.
Perioperative stroke. Administrative data identiﬁed
26 perioperative strokes, whereas chart review identiﬁed
27. Of the 26 strokes identiﬁed by administrative data,
18 were true perioperative strokes and eight were false
positive identiﬁcations. Nine perioperative strokes were
missed entirely by administrative data. Table IV lists the
explanations for the eight false positive and nine false
negative perioperative strokes identiﬁed by administrative
data. The sensitivity of administrative data for determining
perioperative strokes is 66.7%, speciﬁcity 99.4%, PPV
69.2%, and NPV 99.3%. The kappa is 0.67 indicating fair to
good agreement with chart review (Table III).
Comparison of NSQIP data and physician chart review
When comparing NSQIP to chart review, NSQIP
identiﬁed more symptomatic patients (44.1% vs 30.3%),
fewer physiologic high-risk patients (13.0% vs 18.6%),
Table III. Sensitivity, speciﬁcity, PPV, NPV, and kappa of administrative data compared with chart review
Sensitivity, % Speciﬁcity, % PPV, % NPV, % Kappa
Symptomatic 36.6 93.1 73.2 74.1 0.34
Physiologic high risk 19.5 93.7 48.0 79.6 0.17
Age >80 years 100 100 100 100 1.00
MI within 30 days 33.3 55.4 1.7 97.2 0.01
Unstable angina 6.3 100 100 96.2 0.11
CHF class III or IV 10.0 0.4 0.8 96.6 0.03
LVEF <30% - - - - -
Hemodialysis 61.5 73.6 7.4 98.2 0.08
Severe pulmonary diseasea 46.7 35.5 2.8 94.4 0.02
CABG/valve repair within 30 days 66.7 100 100 95.6 0.78
Perioperative stroke 66.7 99.4 69.2 99.3 0.67
CABG, Coronary artery bypass grafting; CHF, congestive heart failure; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NPV, negative
predictive value; PPV, positive predictive value.
aForced expiratory volume in 1 second <30% of predicted or on home oxygen.
Table IV. Explanations for the eight false positive
strokes and nine false negative strokes identiﬁed by
administrative data
Eight false positive perioperative strokes
Four patients were falsely coded as having a perioperative stroke
One preoperative stroke was miscoded as being a postoperative
stroke
Three strokes occurred after admission to the hospital for other
reasons
One occurred after a laparoscopic cholecystectomy
One occurred after admission to the hospital for treatment of
pneumonia
One occurred after admission to the hospital for lower
extremity ischemia
Nine false negative perioperative strokes
Three were postdischarge strokes
Two were misclassiﬁed as preoperative strokes
Four strokes were not coded at all in the discharge data
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proportion of perioperative strokes (1.5% vs 1.8%). When
examining individual high-risk variables, NSQIP overesti-
mated recent MI, unstable angina, CHF, and severe
pulmonary disease, whereas underestimating LVEF <30%
and hemodialysis (Table V). There was complete agree-
ment in identifying patients >80 years and those who
underwent CABG/valve repair. NSQIP is unable to iden-
tify anatomic high-risk variables.
Symptom status. NSQIP identiﬁed 173 symptomatic
patients, whereas chart review identiﬁed 119. Of the
173 patients identiﬁed by NSQIP, 109 were truly symp-
tomatic. This means that 10 of the 119 symptomatic
patients identiﬁed by chart review were misclassiﬁed as
being asymptomatic using NSQIP. The sensitivity of
NSQIP for determining symptomatic status is 91.6%, spec-
iﬁcity 76.6%, PPV 63.0%, and NPV 95.4%. The kappa of
NSQIP is 0.60 indicating fair to good agreement between
NSQIP and chart review (Table VI).High-risk status. NSQIP identiﬁed 51 physiologic
high-risk patients, whereas chart review identiﬁed 73.
Only 10 of the 51 were truly physiologic high-risk patients
leaving 63 of the 73 misclassiﬁed by NSQIP as being non-
high risk. The sensitivity of NSQIP for determining high-
risk status is 13.7%, speciﬁcity 98.4%, PPV 58.3%, and
NPV 82.6%. The kappa of NSQIP is 0.01, indicating poor
agreement between NSQIP and chart review. There was
also poor concordance with the individual high-risk vari-
ables with the exception of age >80 years, hemodialysis,
and CABG/valve repair (kappa of 1.00, 0.75, and 1.00,
respectively, indicating excellent agreement) (Table VI).
The kappa for the other high-risk variables ranges
from 0.01 to 0.21 indicating poor agreement.
Perioperative stroke. NSQIP identiﬁed six periopera-
tive strokes, whereas chart review identiﬁed seven. There
was one false negative stroke and zero false positives with
NSQIP. This one missed perioperative stroke was simply
not captured by the person responsible for NSQIP data
input. The sensitivity of NSQIP for determining perioper-
ative stroke is 85.7%, speciﬁcity 100%, PPV 100%, and
NPV 99.7%. The kappa of NSQIP is 0.92, indicating excel-
lent agreement with chart review (Table VI).
DISCUSSION
Many studies have used administrative data to study
patients undergoing CEA or CAS.1-3 The beneﬁt of these
databases is their large sample size, whereas the downside
is their reliance on ICD-9 hospital discharge coding.
With this study, we sought to examine the accuracy of
ICD-9 coding compared with chart review, and we have
found poor concordance between administrative and clin-
ical data. Administrative data are poor at determining
symptom status and high-risk status. Although periopera-
tive stroke rates were similar between administrative data
and chart review, administrative data identiﬁed the wrong
patients and had poor accuracy. NSQIP data were also
poor at determining high-risk status, but were accurate
for determination of perioperative strokes and to a lesser
extent symptom status.
Table V. Comparison of outcomes analysis using NSQIP
data and physician chart review in 392 patients who
underwent CEA between 2005 and 2011
NSQIP
data
Physician
chart
review
No. % No. %
Symptomatic 173 44.1 119 30.3
Physiologic high risk 51 13.0 73 18.6
Age >80 years 76 19.4 76 19.4
Recent MI 7 1.8 2 0.5
Unstable angina 8 2.0 1 0.3
CHF class III or IV 3 0.8 0 0.0
LVEF <30% - - 4 1.0
Hemodialysis 3 0.8 5 1.3
Severe pulmonary diseasea 41 10.4 4 1.0
CABG/valve repair within 30 days 3 0.8 3 0.8
Anatomic high risk - - 26 6.6
Contralateral ICA occlusion - - 20 5.1
Restenosis after CEA - - 15 3.8
Prior neck surgery - - 4 1.0
Contralateral laryngeal nerve palsy - - 0 0.0
History of neck irradiation - - 2 0.5
High or low lesion - - 2 0.5
Perioperative stroke 6 1.5 7 1.8
CABG, Coronary artery bypass grafting; CEA, carotid endarterectomy;
CHF, congestive heart failure; ICA, internal carotid artery; LVEF, left
ventricular ejection fraction; MI, myocardial infarction; NSQIP, National
Surgical Quality Improvement Program.
aForced expiratory volume in 1 second <30% of predicted or home oxygen.
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tifying symptom status and physiologic high-risk status
with administrative data. Recently, the validity of prior
studies utilizing administrative data to compare outcomes
after CEA and CAS has been questioned.4 Our results vali-
date this question as we have found that administrative data
cannot accurately determine symptom status. ICD-9 codes
lack the speciﬁcity needed to accurately determine the
extent and severity of a patient’s comorbid condition,
lack laterality of disease, and lack the temporal timing of
onset. Because of this lack of detail, the use of ICD-9 codes
to determine high-risk status may overestimate certain indi-
vidual high-risk variables such as class III/IV CHF, recent
MI, severe pulmonary disease, and hemodialysis. For
example, when examining the rate of recent MI, adminis-
trative data identiﬁed 174 patients, whereas chart review
identiﬁed nine. This discrepancy is due to the lack of spec-
iﬁcity and timing of ICD-9 codes. ICD-9 diagnosis code
412 is used for myocardial infarction. However, it does
not specify timing of the MI (within the past 30 days or
remote). Chart review was able to determine that only
nine patients had a MI within 30 days of their carotid
procedure. Furthermore, there are no ICD-9 codes avail-
able to estimate anatomic high-risk status.
Other studies have examined the accuracy with which
acute ischemic strokes are identiﬁed with administrative
data, but not in the setting of CEA. Goldstein12 reported
that only 79% of patients with a primary dischargediagnosis indicating cerebral infarction actually had an
acute stroke and that 7% of patients with an ICD-9 code
indicating the absence of cerebral infarction actually had
an acute stroke. Reker et al 13 also showed that there is
incredible variability in which ICD-9 code is reported to
indicate an acute stroke and to the accuracy with which
these codes actually represent new strokes. The rates of
perioperative stroke were similar in our study, but this is
misleading. Administrative data falsely identiﬁed patients
as having a perioperative stroke and failed to identify others
that did. In our study, three of 27 patients experienced
their perioperative stroke after discharge from the hospital.
Postdischarge events are not captured with hospital
discharge data, and this highlights a very important limita-
tion of most administrative datasets. Studies have shown
that in-hospital data underestimates the true risk of perio-
perative stroke.5,6,14 NSQIP, however, provides data on
outcomes out to 30 days. We believe that true periopera-
tive outcomes include 30-day outcomes and our study
highlights that administrative data underestimates the
true 30-day perioperative risk. In the setting of CEA, the
analysis is further complicated by the distinction of preop-
erative stroke (indicating CEA for symptomatic disease) vs
a postoperative complication, as stroke is a difﬁcult
endpoint to measure accurately with administrative data.
Mortality, however, is a hard endpoint and can be accu-
rately determined with administrative data.15,16
We found NSQIP to be poor at determining high-risk
status most likely due to the different deﬁnitions NSQIP
uses to deﬁne patient comorbid conditions. CMS has
speciﬁc high-risk criteria and the NSQIP deﬁnition of these
differs substantially. CMS is more speciﬁc and speciﬁes
a greater severity of disease and/or a shorter timeframe
for an event to occur. Prior studies have used NSQIP to
analyze CEA. One study by Kang et al9 did not attempt
to determine symptom status because NSQIP does not
provide laterality (of symptoms or procedure) and only
states if the patient has a history of TIA or stroke and
does not provide timing of the event. Gupta et al17 did
stratify patients by symptom status. Similar to our analysis,
they speciﬁed that a patient was symptomatic if they had
a history of a prior TIA or stroke and found a similar
proportion of symptomatic patients (43.5% vs 44.1%).
This methodology overestimates the number of symptom-
atic patients as the sensitivity was 91.6% but the PPV was
only 63.0%. This indicates that NSQIP is more accurate
at identifying those patients who are truly symptomatic
but also identiﬁes patients in whom stroke or TIA was likely
more than 6 months before their CEA procedure or contra-
lateral, thus, making them asymptomatic. One periopera-
tive stroke was missed by NSQIP, and no false positive
strokes were identiﬁed. NSQIP is more accurate at deter-
mining perioperative strokes but remains poor at identi-
fying high-risk patients and, therefore, has limited value
for comparative effectiveness of CEA and CAS. These limi-
tations of NSQIP have prompted a new iteration of NSQIP
to be created, which is currently in use and now captures
procedure-speciﬁc comorbidities and complications, which
Table VI. Sensitivity, speciﬁcity, PPV, NPV, and kappa of NSQIP data compared with chart review
Sensitivity, % Speciﬁcity, % PPV, % NPV, % Kappa
Symptomatic 91.6 76.6 63.0 95.4 0.60
Physiologic high risk 13.7 87.1 19.6 81.5 0.01
Age >80 years 100 100 100 100 1.00
MI within 30 days 50.0 98.5 14.3 99.7 0.21
Unstable angina 0.0 98.0 0.0 99.7 0.01
CHF class III or IV 0.0 99.2 0.0 100 0.01
LVEF <30% - - - - -
Hemodialysis 60.0 100 100 99.5 0.75
Severe pulmonary diseasea 75.0 90.2 7.3 99.7 0.11
CABG/valve repair within 30 days 100 100 100 100 1.00
Perioperative stroke 85.7 100 100 99.7 0.92
CABG, Coronary artery bypass grafting; CHF, congestive heart failure; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NPV, negative
predictive value; NSQIP, National Surgical Quality Improvement Program; PPV, positive predictive value.
aForced expiratory volume in 1 second <30% of predicted or on home oxygen.
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ment tool in the future.18
Other large clinical databases such as the Vascular
Study Group of New England (VSGNE) and the
Vascular Quality Initiative (VQI) may be better designed
to accurately study CEA and CAS. The VSGNE is
a regional quality improvement registry that prospectively
collects over 140 data points19 and speciﬁcally identiﬁes
preoperative symptom status, laterality of disease and
procedure, anatomic details, high-risk status, as well as
the laterality of perioperative strokes. This level of clinical
detail makes the VSNGE and VQI valuable research
tools.
Medicare data may provide a higher level of accuracy
compared with purely hospital discharge data since the
timing of prior procedures (eg, CABG) could potentially
be captured using longitudinal data. Additionally, Medi-
care may be useful in determining the date of onset of
new neurologic symptoms or complications, thus, poten-
tially improving the accuracy of determining symptom
status and postprocedure strokes. However, knowledge of
this timing would not be expected to improve the inherent
limitations in the ability to identify postprocedure strokes
or the severity of comorbid conditions that we identiﬁed
in this analysis.
Because of the limitations associated with using admin-
istrative data, a present on admission (POA) indicator has
been developed to improve coding accuracy. The goal of
the POA indicator is to help determine if a diagnosis is
a pre-existing disease, a new diagnosis, or a complication
that occurred during the hospitalization. Prior studies
have shown that the addition of a POA indicator more
accurately characterized preexisting conditions from
complications.20,21 This should help in determining if
a stroke is a perioperative complication or the reason for
the procedure. However, the POA indicator will not aid
in determining high-risk status, as the current ICD-9 codes
are less speciﬁc than needed. Improved education of
hospital coders may improve the accuracy and reliability
of administrative data. ICD-10 codes should improvediagnostic accuracy with regards to symptom status,
high-risk status, and perioperative strokes, but the extent
of this improvement cannot be determined until ICD-10
codes are fully implemented.
As stated earlier, administrative data have well known
limitations. NSQIP is a clinical database; however, it is
expensive and voluntary. NSQIP only captures a random
selection of all CEAs performed at an institution and
does not collect data on CAS. The preoperative character-
istics and postoperative complications collected are not
procedure speciﬁc, NSQIP has deﬁnitions of comorbid
conditions that differ from CMS, and it does not capture
anatomic high-risk criteria. NSQIP does specify a history
of TIA or stroke but provides no details on the timing or
laterality.
Physician chart review is susceptible to limitations as
well. Despite thorough review, information can be over-
looked and missed entirely. The accuracy of chart review
is reliant upon complete and accurate documentation
within the chart. Minor periprocedural strokes may be
missed by the clinician or not entered into the medical
record. As this is a retrospective review, not all patients
were evaluated by a neurologist or had neuroimaging.
The true “gold standard” for accurately determining
comorbidities and complications is uncertain. However,
we believe that physician chart review is the most accurate
method available for retrospective analysis. Clearly, further
comparisons will be needed to monitor the progress of
each of these systems and the relative value of each for
answering various clinical questions.
CONCLUSIONS
Administrative data are poor at determining symptom
status, high-risk status, and accurately detecting periopera-
tive strokes after CEA and CAS. This is in large part due to
the lack of speciﬁcity with ICD-9 diagnosis codes as they
fail to provide information on the severity, laterality, and
temporal onset of disease. However, although NSQIP
does not adequately identify high-risk patients, it is more
accurate at determining perioperative strokes and to a lesser
JOURNAL OF VASCULAR SURGERY
Volume 58, Number 2 Kresowik 419degree, symptom status. The new iteration of NSQIP, as
it captures procedure-speciﬁc comorbid conditions and
complications, will make this an even more robust database
in the future.
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This report by Bensley et al emphasizes the important concept
that databases are not all “created equal,” and thus, it is essential
that the limitations of any database be recognized when drawing
conclusions from analyses. Some of the differences identiﬁed in
their report are a result of differences in deﬁnition between data-
bases rather than “accuracy” per se. This has long been a problem
for carotid procedures.
By far, the most important patient-related determinant of risk
for a carotid intervention is symptom status. Problems arise from
the historic division of symptom status into only two stratad
symptomatic and asymptomaticdand that clinical reports and even
randomized trials have used different deﬁnitions of symptomatic.
I submit that at least three levels of cerebrovascular symptom
status and standardized deﬁnitions are necessary: asymptomatic(never symptomatic in any distribution), symptomatic (recent,
ipsilateral hemispheric or ocular symptoms), and other symptom-
atic (remote ipsilateral or any contralateral or global/vertebrobasi-
lar symptoms). The use of these three strata and deﬁnitions reliably
predict the risk of carotid endarterectomy.1
The current report clearly identiﬁes some of the limitations of
current administrative databases vis-à-vis clinical registries. I do not
think, however, that one can assume that clinical registries, such as
the National Surgical Quality Improvement Program or the
Society for Vascular Surgery Vascular Quality Initiative, are feasible
or even necessarily superior to administrative databases for all the
potential uses of procedural outcome data. There is tremendous
current pressure to have outcome performance measures available
for accountability, such as public reporting or pay-for-performance
